Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.
- Citation:
- Br J Haematol vol 140 (3) 313-9
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Sonali M Smith David Grinblatt Jeffrey L Johnson Donna Niedzwiecki David Rizzieri Nancy L Bartlett Bruce D Cheson
- Networks:
- Study
- CALGB-50002
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Aged, 80 and over, Disease-Free Survival, Drug Administration Schedule, Female, Humans, Immunosuppressive Agents, Lymphoma, Non-Hodgkin, Male, Middle Aged, Recurrence, Remission Induction, Thalidomide, Thromboembolism, Treatment Failure